NO971305L - Sammensetninger og fremgangsmåter for behandling av mast-celleinflammatorisk tilstand - Google Patents
Sammensetninger og fremgangsmåter for behandling av mast-celleinflammatorisk tilstandInfo
- Publication number
- NO971305L NO971305L NO971305A NO971305A NO971305L NO 971305 L NO971305 L NO 971305L NO 971305 A NO971305 A NO 971305A NO 971305 A NO971305 A NO 971305A NO 971305 L NO971305 L NO 971305L
- Authority
- NO
- Norway
- Prior art keywords
- compositions
- methods
- mast cell
- inflammatory condition
- cell inflammatory
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/32—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C271/34—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of rings other than six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31226994A | 1994-09-23 | 1994-09-23 | |
| PCT/US1995/011814 WO1996009297A1 (en) | 1994-09-23 | 1995-09-14 | Compositions and methods for treating mast-cell inflammatory condition |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO971305D0 NO971305D0 (no) | 1997-03-20 |
| NO971305L true NO971305L (no) | 1997-05-06 |
| NO309605B1 NO309605B1 (no) | 2001-02-26 |
Family
ID=23210670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO971305A NO309605B1 (no) | 1994-09-23 | 1997-03-20 | Nye piperazinforbindelser, farmasöytiske preparater inneholdende slike forbindelser, og deres anvendelse |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US6022969A (no) |
| EP (1) | EP0782571A1 (no) |
| JP (1) | JPH10506390A (no) |
| KR (1) | KR970706267A (no) |
| CN (1) | CN1160398A (no) |
| AU (1) | AU694275B2 (no) |
| CA (1) | CA2200561A1 (no) |
| CZ (1) | CZ87097A3 (no) |
| EE (1) | EE03525B1 (no) |
| FI (1) | FI971171A (no) |
| HR (1) | HRP950499B1 (no) |
| HU (1) | HUT77770A (no) |
| IL (1) | IL115405A (no) |
| LT (1) | LT4234B (no) |
| LV (1) | LV11865B (no) |
| MX (1) | MX9702125A (no) |
| NO (1) | NO309605B1 (no) |
| NZ (1) | NZ294392A (no) |
| PL (1) | PL183552B1 (no) |
| RU (1) | RU2159229C2 (no) |
| SI (1) | SI9520101A (no) |
| SK (1) | SK37997A3 (no) |
| TW (1) | TW442478B (no) |
| WO (1) | WO1996009297A1 (no) |
| ZA (1) | ZA958028B (no) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20000029679A (ko) * | 1996-07-30 | 2000-05-25 | 헤이즈 더블유.그쉬웬드 다니엘 에이치.페트리 | 트립타아제활성관련질병을치료하기위한화합물및조성물 |
| US5968782A (en) * | 1996-12-04 | 1999-10-19 | Brigham And Womens's Hospital, Inc. | Mast cell protease that cleaves fibrinogen |
| WO1998033812A1 (en) * | 1997-02-05 | 1998-08-06 | Brigham And Women's Hospital, Inc. | Mast cell protease peptide inhibitors |
| AU8997498A (en) * | 1997-09-05 | 1999-03-29 | Yoshitomi Pharmaceutical Industries, Ltd. | Tryptase inhibitor |
| US6221914B1 (en) | 1997-11-10 | 2001-04-24 | Array Biopharma Inc. | Sulfonamide bridging compounds that inhibit tryptase activity |
| AU1208999A (en) * | 1997-11-10 | 1999-05-31 | Array Biopharma, Inc. | Compounds which inhibit tryptase activity |
| JP2002502850A (ja) * | 1998-02-06 | 2002-01-29 | マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ | トリプターゼ阻害物質 |
| AU2723099A (en) | 1998-02-06 | 1999-08-23 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Tryptase inhibitors |
| WO2000014097A2 (de) * | 1998-09-04 | 2000-03-16 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Neue pyranosen |
| US6362216B1 (en) | 1998-10-27 | 2002-03-26 | Array Biopharma Inc. | Compounds which inhibit tryptase activity |
| AU3731400A (en) * | 1999-03-05 | 2000-09-21 | Trustees Of University Technology Corporation, The | Methods and compositions useful in inhibiting apoptosis |
| US6849605B1 (en) * | 1999-03-05 | 2005-02-01 | The Trustees Of University Technology Corporation | Inhibitors of serine protease activity, methods and compositions for treatment of viral infections |
| US6673786B1 (en) | 1999-08-10 | 2004-01-06 | Altana Pharma Ag | Tryptase inhibitors |
| JP2003509417A (ja) * | 1999-09-14 | 2003-03-11 | アルタナ ファルマ アクチエンゲゼルシャフト | トリプターゼインヒビター |
| GB9923710D0 (en) * | 1999-10-08 | 1999-12-08 | Proteus Molecular Design | Chemical compounds |
| AU1413301A (en) * | 1999-11-17 | 2001-05-30 | Sumitomo Pharmaceuticals Company, Limited | Diabetic remedy containing dipiperazine derivative |
| TR200402164T4 (tr) | 1999-12-20 | 2004-10-21 | Altana Pharma Ag | Triptaz inhibitörler |
| US7015325B2 (en) * | 1999-12-20 | 2006-03-21 | Altana Pharma Ag | Tryptase inhibitors |
| WO2001052883A1 (en) * | 2000-01-20 | 2001-07-26 | Amgen Inc. | Inhibitors of protease-activated receptor-2 (par-2) as novel asthma therapeutics |
| US20020045613A1 (en) * | 2000-04-27 | 2002-04-18 | Heinz Pauls | 1-aroyl-piperidinyl benzamidines |
| CA2438594A1 (en) * | 2001-01-31 | 2002-08-08 | Altana Pharma Ag | Diazocine derivatives and their use as tryptase inhibitors |
| CA2438685A1 (en) | 2001-02-21 | 2002-08-29 | Altana Pharma Ag | Tryptase inhibitors |
| WO2002066420A2 (en) * | 2001-02-21 | 2002-08-29 | Altana Pharma Ag | Tryptase inhibitors |
| EP1370518A2 (en) * | 2001-03-15 | 2003-12-17 | ALTANA Pharma AG | Tryptase-inhibitors |
| WO2002074732A2 (en) * | 2001-03-15 | 2002-09-26 | Altana Pharma Ag | Tryptase-inhibitors |
| US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| US6818787B2 (en) * | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| US7186855B2 (en) | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| US7232924B2 (en) * | 2001-06-11 | 2007-06-19 | Xenoport, Inc. | Methods for synthesis of acyloxyalkyl derivatives of GABA analogs |
| ATE348803T1 (de) | 2001-06-19 | 2007-01-15 | Altana Pharma Ag | Tryptase-inhibitoren |
| JP2005523883A (ja) * | 2001-12-13 | 2005-08-11 | 興和株式会社 | 遅延型過敏症予防・治療用医薬組成物 |
| WO2003075853A2 (en) | 2002-03-08 | 2003-09-18 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
| TW200524849A (en) * | 2003-07-02 | 2005-08-01 | Hoffmann La Roche | Hydroxyalkylamide derivatives |
| US20050255154A1 (en) * | 2004-05-11 | 2005-11-17 | Lena Pereswetoff-Morath | Method and composition for treating rhinitis |
| TW200815351A (en) * | 2006-05-02 | 2008-04-01 | Astrazeneca Ab | Novel compounds |
| TWI414527B (zh) * | 2010-10-06 | 2013-11-11 | Ind Tech Res Inst | 異山梨糖醇衍生物及包含該衍生物之液晶顯示器 |
| CN102453037B (zh) * | 2010-10-25 | 2014-06-25 | 财团法人工业技术研究院 | 异山梨糖醇衍生物及包含该衍生物的液晶显示器 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR208414A1 (es) * | 1974-11-07 | 1976-12-27 | Rhone Poulenc Ind | Procedimiento para obtener nuevos derivados de la((acil-4piperazinil-1)carboniloxi-5 pirrolinona-2) |
| US4746737A (en) * | 1985-07-26 | 1988-05-24 | Kowa Co., Ltd. | Phenyl guanidinobenzoate derivatives which have protease inhibitory activity |
| US5525623A (en) * | 1993-03-12 | 1996-06-11 | Arris Pharmaceutical Corporation | Compositions and methods for the treatment of immunomediated inflammatory disorders |
| UA42719C2 (uk) * | 1993-03-12 | 2001-11-15 | Аксіз Фармасьютікелз, Інк | Сполуки, композиції та способи, які інгібують протеази, для лікування та профілактики імуномедіаторних запальних хвороб |
| JPH10501238A (ja) * | 1994-06-01 | 1998-02-03 | アリス ファーマシューティカル コーポレイション | 肥満細胞媒介症状を治療するための組成物及び方法 |
-
1995
- 1995-09-14 EP EP95934993A patent/EP0782571A1/en not_active Withdrawn
- 1995-09-14 CN CN95195191A patent/CN1160398A/zh active Pending
- 1995-09-14 PL PL95319587A patent/PL183552B1/pl unknown
- 1995-09-14 RU RU97106347/04A patent/RU2159229C2/ru not_active IP Right Cessation
- 1995-09-14 SI SI9520101A patent/SI9520101A/sl unknown
- 1995-09-14 JP JP8511002A patent/JPH10506390A/ja not_active Ceased
- 1995-09-14 US US08/522,157 patent/US6022969A/en not_active Expired - Fee Related
- 1995-09-14 EE EE9700089A patent/EE03525B1/xx not_active IP Right Cessation
- 1995-09-14 AU AU37180/95A patent/AU694275B2/en not_active Ceased
- 1995-09-14 SK SK379-97A patent/SK37997A3/sk unknown
- 1995-09-14 MX MX9702125A patent/MX9702125A/es not_active IP Right Cessation
- 1995-09-14 CZ CZ97870A patent/CZ87097A3/cs unknown
- 1995-09-14 CA CA002200561A patent/CA2200561A1/en not_active Abandoned
- 1995-09-14 HU HU9702059A patent/HUT77770A/hu unknown
- 1995-09-14 NZ NZ294392A patent/NZ294392A/xx unknown
- 1995-09-14 WO PCT/US1995/011814 patent/WO1996009297A1/en not_active Application Discontinuation
- 1995-09-14 KR KR1019970701960A patent/KR970706267A/ko not_active Application Discontinuation
- 1995-09-22 IL IL11540595A patent/IL115405A/en not_active IP Right Cessation
- 1995-09-22 HR HR950499A patent/HRP950499B1/xx not_active IP Right Cessation
- 1995-09-22 ZA ZA958028A patent/ZA958028B/xx unknown
- 1995-09-26 TW TW084110031A patent/TW442478B/zh active
-
1997
- 1997-03-20 NO NO971305A patent/NO309605B1/no unknown
- 1997-03-20 FI FI971171A patent/FI971171A/fi unknown
- 1997-04-10 LT LT97-065A patent/LT4234B/lt not_active IP Right Cessation
- 1997-04-22 LV LVP-97-70A patent/LV11865B/en unknown
-
1999
- 1999-03-29 US US09/280,227 patent/US6211228B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1160398A (zh) | 1997-09-24 |
| HRP950499A2 (en) | 1997-08-31 |
| EE03525B1 (et) | 2001-10-15 |
| JPH10506390A (ja) | 1998-06-23 |
| CA2200561A1 (en) | 1996-03-28 |
| IL115405A0 (en) | 1995-12-31 |
| CZ87097A3 (en) | 1997-11-12 |
| TW442478B (en) | 2001-06-23 |
| EE9700089A (et) | 1997-10-15 |
| MX9702125A (es) | 1998-04-30 |
| US6022969A (en) | 2000-02-08 |
| WO1996009297A1 (en) | 1996-03-28 |
| IL115405A (en) | 2002-07-25 |
| AU694275B2 (en) | 1998-07-16 |
| LT97065A (en) | 1997-08-25 |
| SI9520101A (en) | 1997-12-31 |
| NO309605B1 (no) | 2001-02-26 |
| FI971171A0 (fi) | 1997-03-20 |
| RU2159229C2 (ru) | 2000-11-20 |
| HRP950499B1 (en) | 2003-04-30 |
| ZA958028B (en) | 1996-04-18 |
| PL183552B1 (pl) | 2002-06-28 |
| LT4234B (en) | 1997-10-27 |
| EP0782571A1 (en) | 1997-07-09 |
| KR970706267A (ko) | 1997-11-03 |
| NZ294392A (en) | 1999-05-28 |
| AU3718095A (en) | 1996-04-09 |
| PL319587A1 (en) | 1997-08-18 |
| NO971305D0 (no) | 1997-03-20 |
| US6211228B1 (en) | 2001-04-03 |
| FI971171A (fi) | 1997-03-20 |
| HUT77770A (hu) | 1998-08-28 |
| LV11865A (lv) | 1997-10-20 |
| SK37997A3 (en) | 1998-12-02 |
| LV11865B (en) | 1998-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO971305L (no) | Sammensetninger og fremgangsmåter for behandling av mast-celleinflammatorisk tilstand | |
| NO20003096D0 (no) | Sammensetninger og fremgangsmÕter for behandling av ADD | |
| NO992297D0 (no) | FremgangsmÕte og nye forbindelser | |
| DE69732084D1 (de) | Pulsladeverfahren und ladegerät | |
| NO973464D0 (no) | Forlengingsrör - avskraperpluggapparat og fremgangsmåte | |
| DE69526144T2 (de) | Leistungsverstärker | |
| NO994778L (no) | Fremgangsmåter og preparater for behandling av inflammatorisk tarmsyndrom | |
| FI961154A (fi) | Menetelmä ja järjestely matkapuhelimen käytön rajoittamiseksi | |
| FI110218B (fi) | Menetelmiä ja laitteisto sähkökemiallisten laitteiden jäähtymisen estämiseksi | |
| FI944363A (fi) | Päätelaite | |
| DE69526670T2 (de) | Kühlturm und konstruktionsverfahren | |
| DE69724552D1 (de) | Leistungsverstärkerapparat | |
| FI101285B (fi) | Nostolaitteisto | |
| DE69506159T2 (de) | Luftgekühlte Last und Scheinantenne | |
| NO964898D0 (no) | Elektrokjemisk anlegg | |
| NO20001011D0 (no) | System og fremgangsmõte for mõling av effekt | |
| NO952766L (no) | Opplösningsmiddelsammensetninger og metoder | |
| DE69722799D1 (de) | Zellzusammenstellungen | |
| ITMI940278A0 (it) | Metodo e apparecchiatura per essiccare sanse | |
| DE69514758T2 (de) | Wägezellen | |
| DE29613833U1 (de) | Kraftmeßdose | |
| FI974619A (fi) | Menetelmä kattoristikkoelementtien valmistamiseksi ja menetelmässä käytettävä laite | |
| KR960001641U (ko) | 벽돌 적재장치에 있어 벽돌 정열구조 | |
| FI962553A (fi) | Matkaviestinmaksumenetelmä ja laitteet | |
| FI945329A0 (fi) | Testanlaeggning foer en basstation i en utvidgad cell |